We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 90

Health Canada publishes guidance for industry on the reporting of incidents involving consumer products
  • Stikeman Elliott LLP
  • Canada
  • July 13 2015

On July 8, 2015, Health Canada released important guidance designed to help consumer product companies, including retailers, understand their


Competition Bureau sets out preliminary views on patent agreement settlement enforcement
  • Stikeman Elliott LLP
  • Canada
  • October 27 2014

On September 23, 2014, John Pecman, the Commissioner of Competition, delivered the keynote address at the George Mason University Pharma Conference


Federal Court opines on precedential value of prior PM(NOC) proceedings and scope of experimental use exception to public disclosure
  • Stikeman Elliott LLP
  • Canada
  • November 24 2016

The Federal Court’s decision inthe consolidated proceedings of Bayer Inc. v Cobalt Pharmaceuticals Company offers useful guidance as to the


Supreme Court of Canada affirms constitutionality of provincial breathalyzer laws
  • Stikeman Elliott LLP
  • Canada
  • October 22 2015

The Supreme Court released its decision on October 16, 2015 in the case of Goodwin v. British Columbia (Superintendent of Motor Vehicles) dealing


Snoops and gossips beware: Ontario Government to introduce stiffer measures to protect patient privacy
  • Stikeman Elliott LLP
  • Canada
  • June 26 2015

Recently, the Government of Ontario announced its intent to strengthen the rules protecting patient privacy. If passed, these amendments to the


Government seeks feedback on new drug safety initiatives
  • Stikeman Elliott LLP
  • Canada
  • May 6 2015

As previously reported, the Food and Drugs Act (the Act) has been substantively amended by Bill C-17, also known as Vanessa's Law; the Bill received


British Columbia Court of Appeal overturns certification of pharmaceutical class action
  • Stikeman Elliott LLP
  • Canada
  • February 20 2015

In a decision released January 22, 2015, the B.C. Court of Appeal unanimously overturned an order certifying a class proceeding against the


Health Canada releases guidance on “danger to human health or safety” posed by consumer products
  • Stikeman Elliott LLP
  • Canada
  • December 20 2013

Health Canada has released a guidance document on factors it will consider when determining whether a consumer product poses a "danger to human


Health and environmental claims an ongoing bureau focus
  • Stikeman Elliott LLP
  • Canada
  • December 18 2007

Investigations and enforcement actions over marketing and advertising claims related to health products and services have been a significant part of the Bureau's recent fair-business-practices work


Health Canada Releases Annual Compliance and Enforcement Report for Fiscal Year 2015-2016
  • Stikeman Elliott LLP
  • Canada, USA
  • November 2 2016

In October 2016, the Consumer Product Safety Program (CPSP), a division of Health Canada, released its annual Compliance and Enforcement Report for